Research Paper Advance Articles
Unveiling KLHL23 as a key immune regulator in hepatocellular carcinoma through integrated analysis
Figure 1. The differential expression of KLHL23 in human tumors and healthy tissues among the 33 types of cancer. (A) The black and yellow bar graphs indicate KLHL23 levels in normal and tumor tissue. (B–J) Pan-cancer differential expression of KLHL23 in paired tumor and adjacent normal tissue in the indicated, represents tumor types (liver hepatocellular carcinoma (LIHC), LUAD, KIRC, PRAD, CHOL, COAD, ESCA, PCPG, and SARC) from the TCGA database. (K–N) KLHL23 mRNA expression levels in diverse stages of the indicated tumor types from the TCGA database (LIHC, LUAD, KIRC, ESCA). Blue and red bars indicate normal and tumor tissue KLHL23 levels (*P < 0.05, **P < 0.01, ***P < 0.001).